Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02533089Not ApplicableCompleted

Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi

Role: lead

NCT03520621Completed

The Role of Sulfur Amino Acids in Risk of Kwashiorkor

Role: collaborator

NCT02005835Not ApplicableUnknown

Promoting Uptake and Retention of Option B+ in Malawi

Role: collaborator

NCT01356095Not ApplicableCompleted

A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi

Role: lead

All 4 trials loaded